Novartis AG (NVSN) — Free Cash Flow Generation Index
Novartis AG (NVSN) has a Free Cash Flow Generation Index of 0.78x as of March 2026. Free cash flow of MX$2.87 Billion represents 1% of operating cash flow (MX$3.68 Billion). Explore NVSN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Novartis AG Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Novartis AG across 12 annual periods. For the full cash flow conversion analysis, see NVSN operating cash flow.
Annual Free Cash Flow Generation for Novartis AG (2014–2025)
Year-by-year Free Cash Flow Generation Index for Novartis AG. Check NVSN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (MXN) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | MX$15.24 Billion | MX$19.14 Billion | MX$3.90 Billion | ▲ +1.6% |
| 2024 | 0.78x | MX$13.80 Billion | MX$17.62 Billion | MX$3.81 Billion | ▼ -4.3% |
| 2023 | 0.82x | MX$13.12 Billion | MX$16.02 Billion | MX$2.90 Billion | ▲ +0.8% |
| 2022 | 0.81x | MX$11.56 Billion | MX$14.24 Billion | MX$1.20 Billion | ▲ +1.2% |
| 2021 | 0.80x | MX$12.10 Billion | MX$15.07 Billion | MX$1.38 Billion | ▼ -1.0% |
| 2020 | 0.81x | MX$11.06 Billion | MX$13.65 Billion | MX$1.27 Billion | ▼ -2.8% |
| 2019 | 0.83x | MX$11.37 Billion | MX$13.62 Billion | MX$1.38 Billion | ▲ +9.1% |
| 2018 | 0.76x | MX$10.92 Billion | MX$14.27 Billion | MX$1.25 Billion | ▼ -2.2% |
| 2017 | 0.78x | MX$9.88 Billion | MX$12.62 Billion | MX$1.32 Billion | ▼ -37.5% |
| 2016 | 1.25x | MX$14.35 Billion | MX$11.47 Billion | MX$2.88 Billion | ▲ +4.3% |
| 2015 | 1.20x | MX$14.26 Billion | MX$11.90 Billion | MX$2.37 Billion | ▲ +0.9% |
| 2014 | 1.19x | MX$16.52 Billion | MX$13.90 Billion | MX$2.62 Billion | — |